Humberto Lara Guerra
Humberto Lara Guerra
Verified email at
Cited by
Cited by
Incidental germline variants in 1000 advanced cancers on a prospective somatic genomic profiling protocol
F Meric-Bernstam, L Brusco, M Daniels, C Wathoo, AM Bailey, L Strong, ...
Annals of Oncology 27 (5), 795-800, 2016
Peripheral lung nodules: fluoroscopically guided video-assisted thoracoscopic resection after computed tomography-guided localization using platinum microcoils
TI Powell, D Jangra, JC Clifton, H Lara-Guerra, N Church, J English, ...
Annals of surgery 240 (3), 481, 2004
Phase II study of preoperative gefitinib in clinical stage I non-small-cell lung cancer
H Lara-Guerra, TK Waddell, MA Salvarrey, AM Joshua, CT Chung, N Paul, ...
Journal of Clinical Oncology 27 (36), 6229, 2009
Comparison of computer-assisted instruction (CAI) versus traditional textbook methods for training in abdominal examination (Japanese experience)
KY Qayumi AK, Kurihara Y, Imai M, Pachev G, Seo H, Hoshino Y, Cheifetz R ...
Medical Education 38 (10), 1080-1088, 2004
The role of intrapulmonary de novo lymphoid tissue in obliterative bronchiolitis after lung transplantation
M Sato, S Hirayama, DM Hwang, H Lara-Guerra, D Wagnetz, TK Waddell, ...
The Journal of Immunology 182 (11), 7307-7316, 2009
Tissue heterogeneity of EGFR mutation in lung adenocarcinoma
A Sakurada, H Lara-Guerra, N Liu, FA Shepherd, MS Tsao
Journal of Thoracic Oncology 3 (5), 527-529, 2008
Selected reaction monitoring (SRM) analysis of epidermal growth factor receptor (EGFR) in formalin fixed tumor tissue
T Hembrough, S Thyparambil, WL Liao, MM Darfler, J Abdo, KM Bengali, ...
Clinical proteomics 9 (1), 1-10, 2012
The right drugs at the right time for the right patient: the MD Anderson precision oncology decision support platform
A Johnson, J Zeng, AM Bailey, V Holla, B Litzenburger, H Lara-Guerra, ...
Drug discovery today 20 (12), 1433-1438, 2015
Histopathological and immunohistochemical features associated with clinical response to neoadjuvant gefitinib therapy in early stage non-small cell lung cancer
H Lara-Guerra, CT Chung, J Schwock, M Pintilie, DM Hwang, NB Leighl, ...
Lung cancer 76 (2), 235-241, 2012
MMP-dependent migration of extrapulmonary myofibroblast progenitors contributing to posttransplant airway fibrosis in the lung
M Sato, S Hirayama, H Lara-Guerra, M Anraku, TK Waddell, M Liu, ...
American Journal of Transplantation 9 (5), 1027-1036, 2009
Gene therapy for lung cancer
H Lara-Guerra, JA Roth
Critical Reviews™ in Oncogenesis 21 (1-2), 2016
Exogenous restoration of TUSC2 expression induces responsiveness to erlotinib in wildtype epidermal growth factor receptor (EGFR) lung cancer cells through context specific …
B Dai, S Yan, H Lara-Guerra, H Kawashima, R Sakai, G Jayachandran, ...
PloS one 10 (6), e0123967, 2015
CT-directed microcoil localization of small peripheral lung nodules: a feasibility study in pigs
D Jangra, T Powell, SE Kalloger, HL Guerra, J Clifton, HO Coxson, ...
Journal of Investigative Surgery 18 (5), 265-272, 2005
Using Ontology Fingerprints to disambiguate gene name entities in the biomedical literature
G Chen, J Zhao, T Cohen, C Tao, J Sun, H Xu, EV Bernstam, A Lawson, ...
Database 2015, bav034, 2015
Cáncer de mama en mujeres jóvenes en México: necesidades y retos clínicos
C Villarreal-Garza, C Águila, A Platas, H Lara-Guerra
Revista de investigación clínica 66 (6), 547-558, 2014
A window of opportunity study of potential tumor and soluble biomarkers of response to preoperative erlotinib in early stage non-small cell lung cancer
AG Sacher, LW Le, H Lara-Guerra, TK Waddell, S Sakashita, Z Chen, ...
Oncotarget 7 (18), 25632, 2016
Lung adenocarcinoma with concurrent KRAS mutation and ALK rearrangement responding to crizotinib: case report
S Campos-Gomez, H Lara-Guerra, MJ Routbort, X Lu, GR Simon
The International Journal of Biological Markers 30 (2), 254-257, 2015
Evaluación de la utilidad del pericardio bovino en resecciones pulmonares no anatómicas en perros
JR Olmos-Zúñiga, R Jasso-Victoria, A Sotres-Vega, MO Gaxiola-Gaxiola, ...
Rev. invest. clín, 334-341, 2002
Phase 3 study of pembrolizumab with concurrent chemoradiation therapy followed by pembrolizumab with or without olaparib versus concurrent chemoradiation therapy followed by …
SK Jabbour, BC Cho, E Bria, T Kato, J Bhosle, JF Gainor, N Reguart, ...
Journal of Clinical Oncology 39 (15_suppl), TPS8580-TPS8580, 2021
1418TiP Randomized, placebo-controlled phase III study of 1L pembrolizumab (Pembro) plus carboplatin/taxane followed by pembro with or without maintenance olaparib in patients …
JE Gray, TK Owonikoko, T Kato, E Nadal, A Greystoke, AF Cardona, ...
Annals of Oncology 31, S896, 2020
The system can't perform the operation now. Try again later.
Articles 1–20